financetom
Business
financetom
/
Business
/
Macy's Insider Sold Shares Worth $875,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Macy's Insider Sold Shares Worth $875,000, According to a Recent SEC Filing
Sep 12, 2025 1:39 PM

04:16 PM EDT, 09/12/2025 (MT Newswires) -- Danielle L. Kirgan, Executive Vice President, Chief Human Resources Officer, on September 11, 2025, sold 50,000 shares in Macy's (M) for $875,000. Following the Form 4 filing with the SEC, Kirgan has control over a total of 236,161 common shares of the company, with 236,161 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/794367/000079436725000157/xslF345X05/wk-form4_1757707704.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Norway pauses wealth fund's ethical divestments
Norway pauses wealth fund's ethical divestments
Nov 4, 2025
* Parliament pauses ethical divestments amid scrutiny * Finance Minister Stoltenberg cites need to protect fund's value * Government worried about Trump, says Socialist Left lawmaker (Updates throughout with parliament adopting proposal) By Gwladys Fouche OSLO, Nov 4 (Reuters) - Norway's parliament on Tuesday voted in favour of pausing ethical divestments by its $2.1 trillion sovereign wealth fund, the world's...
Form 8.3
Form 8.3
Nov 4, 2025
LONDON--(BUSINESS WIRE)--   Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed,...
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up
Nov 4, 2025
(Reuters) -Novo Nordisk and Pfizer ( PFE ) have revised their bids for Metsera ( MTSR ), the obesity drug developer said on Tuesday. Novo's revised offer brings the deal value to about $10 billion, while Pfizer ( PFE ) is now willing to shell out $8.1 billion. The revised bids come as both companies are engaged in a public...
Pfizer's Core Drugs Offset COVID Revenue Drop, Lifts 2025 Profit Outlook Despite Tariffs
Pfizer's Core Drugs Offset COVID Revenue Drop, Lifts 2025 Profit Outlook Despite Tariffs
Nov 4, 2025
On Tuesday, Pfizer Inc ( PFE ). reported third-quarter 2025 adjusted earnings of 87 cents, compared to $1.06 a year ago, beating the consensus of 63 cents. PFE shares are experiencing downward pressure. Get the inside scoop here Pfizer's ( PFE ) third-quarter sales fell 6% year over year to $16.65 billion, beating the consensus of $16.59 billion. The revenue reflected an...
Copyright 2023-2026 - www.financetom.com All Rights Reserved